Gene testing in antithrombotic therapy is the VKORC1, YP2C9, CYP2C19 genotyping test to assist doctors in predicting response to antiplatelet drugs (Clopidogrel) or anticoagulants vitamin K (AVK).
The value of the test:
- In Europe, thrombosis kills three times more than all deaths from AIDS, breast cancer, prostate cancer or traffic accidents.
- Antiplatelet drugs and vitamin K anticoagulants are widely used and widely used in most of the diseases related to thrombosis.
GENTIS is a pioneer in gene testing in Vietnam, with current technology and equipment. Identify variants of CYP2C19*2 (681G>A) and CYP2C19*3 (636G>A)